Skip to content
Home/Companies/Biotech/Alderaan Biotechnology

Alderaan Biotechnology

Biotech·France·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Alderaan Biotechnology?

Alderaan Biotechnology is currently owned by AdBio Partners through AFB Seed-Fund (2017 vintage), since 2020.

Hand-verified · updated 2026-04-21

AdBio Partners
Investor
AdBio Partners
AFB Seed-Fund · 2017 · VC

Key facts

HQFrance
SectorBiotech

More from AFB Seed-Fund

Other portfolio companies in the same fund.

ARTHEx Biotech
ARTHEx Biotech
Active
BiotechSpain· 2020
GAMUT Therapeutics
Exited 2021
BiotechFrance· 2020
to
Kalsiom
Kalsiom
Active
BiotechFrance· 2020
Wellium
Active
HealthcareFrance· 2020
Agomab Therapeutics
Agomab Therapeutics
Exited 2026
BiotechBelgium· 2019
to
SparingVision
SparingVision
Active
BiotechFrance· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Alderaan Biotechnology

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Alderaan Biotechnology?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Alderaan Biotechnology.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue